Cardinal Health, Inc. (CAH)

$95.42

+0.39

(+0.41%)

Market is closed - opens 7 PM, 23 Jul 2024

Performance

  • $95.00
    $96.70
    $95.42
    downward going graph

    0.44%

    Downside

    Day's Volatility :1.76%

    Upside

    1.32%

    downward going graph
  • $83.40
    $114.93
    $95.42
    downward going graph

    12.6%

    Downside

    52 Weeks Volatility :27.43%

    Upside

    16.98%

    downward going graph

Returns

PeriodCardinal Health, Inc.Sector (Health Care)S&P500
3 Months
-7.69%
5.3%
9.7%
6 Months
-8.72%
6.3%
14.4%
1 Year
2.55%
9.2%
22.7%
3 Years
61.18%
13.1%
26.1%

Highlights

Market Capitalization
23.1B
Book Value
- $13.38
Dividend Share
2.002
Dividend Yield
2.13%
Earnings Per Share (EPS)
2.26
PE Ratio
42.05
PEG Ratio
0.31
Wall Street Target Price
113.61
Profit Margin
0.25%
Operating Margin TTM
1.07%
Return On Assets TTM
2.92%
Return On Equity TTM
0.0%
Revenue TTM
220.6B
Revenue Per Share TTM
891.2
Quarterly Revenue Growth YOY
8.799999999999999%
Gross Profit TTM
6.5B
EBITDA
2.8B
Diluted Eps TTM
2.26
Quarterly Earnings Growth YOY
-0.22
EPS Estimate Current Year
7.36
EPS Estimate Next Year
7.53
EPS Estimate Current Quarter
1.95
EPS Estimate Next Quarter
1.8

Analyst Recommendation

Hold
    45%Buy
    50%Hold
    4%Sell
Based on 22 Wall street analysts offering stock ratings for Cardinal Health, Inc.(by analysts ranked 0 to 5 stars)
Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
8
Hold
11
11
12
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 19.06%

Current $95.42
Target $113.61

Company Financials

FY18Y/Y Change
Revenue
136.8B
↑ 5.26%
Net Income
256.0M
↓ 80.12%
Net Profit Margin
0.19%
↓ 0.8%
FY19Y/Y Change
Revenue
145.5B
↑ 6.38%
Net Income
1.4B
↑ 432.42%
Net Profit Margin
0.94%
↑ 0.75%
FY20Y/Y Change
Revenue
152.9B
↑ 5.08%
Net Income
-3.7B
↓ 370.95%
Net Profit Margin
-2.41%
↓ 3.35%
FY21Y/Y Change
Revenue
162.5B
↑ 6.24%
Net Income
611.0M
↓ 116.54%
Net Profit Margin
0.38%
↑ 2.79%
FY22Y/Y Change
Revenue
181.4B
↑ 11.63%
Net Income
-932.0M
↓ 252.54%
Net Profit Margin
-0.51%
↓ 0.89%
FY23Y/Y Change
Revenue
205.0B
↑ 13.04%
Net Income
261.0M
↓ 128.0%
Net Profit Margin
0.13%
↑ 0.64%
Q4 FY22Q/Q Change
Revenue
51.5B
↑ 3.76%
Net Income
-130.0M
↓ 218.18%
Net Profit Margin
-0.25%
↓ 0.47%
Q1 FY23Q/Q Change
Revenue
50.5B
↓ 1.91%
Net Income
345.0M
↓ 365.38%
Net Profit Margin
0.68%
↑ 0.93%
Q2 FY23Q/Q Change
Revenue
53.5B
↑ 5.87%
Net Income
-64.0M
↓ 118.55%
Net Profit Margin
-0.12%
↓ 0.8%
Q3 FY23Q/Q Change
Revenue
54.8B
↑ 2.45%
Net Income
5.0M
↓ 107.81%
Net Profit Margin
0.01%
↑ 0.13%
Q4 FY23Q/Q Change
Revenue
57.4B
↑ 4.9%
Net Income
353.0M
↑ 6960.0%
Net Profit Margin
0.61%
↑ 0.6%
Q1 FY24Q/Q Change
Revenue
54.9B
↓ 4.41%
Net Income
258.0M
↓ 26.91%
Net Profit Margin
0.47%
↓ 0.14%
FY18Y/Y Change
Total Assets
40.0B
↓ 0.4%
Total Liabilities
33.9B
↑ 1.83%
FY19Y/Y Change
Total Assets
41.0B
↑ 2.53%
Total Liabilities
34.6B
↑ 2.19%
FY20Y/Y Change
Total Assets
40.8B
↓ 0.48%
Total Liabilities
39.0B
↑ 12.53%
FY21Y/Y Change
Total Assets
44.5B
↑ 9.04%
Total Liabilities
42.7B
↑ 9.46%
FY22Y/Y Change
Total Assets
43.9B
↓ 1.29%
Total Liabilities
44.6B
↑ 4.51%
FY23Y/Y Change
Total Assets
43.4B
↓ 1.05%
Total Liabilities
46.3B
↑ 3.78%
Q4 FY22Q/Q Change
Total Assets
44.5B
↑ 2.52%
Total Liabilities
46.7B
↑ 3.38%
Q1 FY23Q/Q Change
Total Assets
43.4B
↓ 2.48%
Total Liabilities
45.6B
↓ 2.35%
Q2 FY23Q/Q Change
Total Assets
43.4B
↑ 0.09%
Total Liabilities
46.3B
↑ 1.48%
Q3 FY23Q/Q Change
Total Assets
43.7B
↑ 0.67%
Total Liabilities
47.2B
↑ 2.01%
Q4 FY23Q/Q Change
Total Assets
46.6B
↑ 6.55%
Total Liabilities
50.0B
↑ 5.97%
Q1 FY24Q/Q Change
Total Assets
45.9B
↓ 1.49%
Total Liabilities
49.1B
↓ 1.76%
FY18Y/Y Change
Operating Cash Flow
2.8B
↑ 133.78%
Investing Cash Flow
-5.6B
↑ 1284.69%
Financing Cash Flow
-2.3B
↓ 160.76%
FY19Y/Y Change
Operating Cash Flow
2.7B
↓ 1.66%
Investing Cash Flow
338.0M
↓ 106.03%
Financing Cash Flow
-2.3B
↑ 0.75%
FY20Y/Y Change
Operating Cash Flow
2.0B
↓ 27.99%
Investing Cash Flow
493.0M
↑ 45.86%
Financing Cash Flow
-2.2B
↓ 4.06%
FY21Y/Y Change
Operating Cash Flow
2.4B
↑ 23.93%
Investing Cash Flow
-378.0M
↓ 176.67%
Financing Cash Flow
-1.3B
↓ 40.14%
FY22Y/Y Change
Operating Cash Flow
3.1B
↑ 28.53%
Investing Cash Flow
567.0M
↓ 250.0%
Financing Cash Flow
-2.5B
↑ 87.02%
FY23Y/Y Change
Operating Cash Flow
2.8B
↓ 9.06%
Investing Cash Flow
-454.0M
↓ 180.07%
Financing Cash Flow
-3.1B
↑ 23.87%
Q4 FY22Q/Q Change
Operating Cash Flow
597.0M
↑ 2495.65%
Investing Cash Flow
-87.0M
↑ 24.29%
Financing Cash Flow
-362.0M
↓ 68.87%
Q1 FY23Q/Q Change
Operating Cash Flow
1.4B
↑ 127.97%
Investing Cash Flow
-91.0M
↑ 4.6%
Financing Cash Flow
-934.0M
↑ 158.01%
Q2 FY23Q/Q Change
Operating Cash Flow
858.0M
↓ 36.96%
Investing Cash Flow
-206.0M
↑ 126.37%
Financing Cash Flow
-592.0M
↓ 36.62%
Q3 FY23Q/Q Change
Operating Cash Flow
545.0M
↓ 36.48%
Investing Cash Flow
-63.0M
↓ 69.42%
Financing Cash Flow
-666.0M
↑ 12.5%

Technicals Summary

Sell

Neutral

Buy

Cardinal Health, Inc. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardinal Health, Inc.
Cardinal Health, Inc.
-9.04%
-8.72%
2.55%
61.18%
114.91%
Cencora Inc
Cencora Inc
-6.12%
3.15%
25.61%
62.7%
94.63%
Mckesson Corporation
Mckesson Corporation
-4.08%
20.11%
41.1%
187.72%
322.13%
Henry Schein, Inc.
Henry Schein, Inc.
5.47%
-4.38%
-10.65%
-8.29%
5.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardinal Health, Inc.
Cardinal Health, Inc.
42.05
42.05
0.31
7.36
0.0
0.03
0.02
-13.38
Cencora Inc
Cencora Inc
23.39
23.39
1.58
11.93
2.34
0.03
0.01
3.39
Mckesson Corporation
Mckesson Corporation
25.91
25.91
4.96
27.59
0.0
0.04
0.0
-15.16
Henry Schein, Inc.
Henry Schein, Inc.
23.68
23.68
1.65
5.07
0.08
0.04
NA
28.02
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$23.1B
114.91%
42.05
0.25%
Cencora Inc
Cencora Inc
Buy
$38.5B
94.63%
23.39
0.66%
Mckesson Corporation
Mckesson Corporation
Buy
$75.2B
322.13%
25.91
0.97%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.0B
5.11%
23.68
3.12%

Insights on Cardinal Health, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 57.44B → 54.91B (in $), with an average decrease of 4.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 353.0M → 258.0M (in $), with an average decrease of 26.9% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 40.7% return, outperforming this stock by 38.3%

  • Vs MCK

    In the last 3 years, Mckesson Corporation has given 187.7% return, outperforming this stock by 126.5%

Institutional Holdings

  • Vanguard Group Inc

    12.57%
  • BlackRock Inc

    11.22%
  • State Street Corporation

    5.79%
  • FMR Inc

    2.38%
  • Geode Capital Management, LLC

    2.29%
  • Morgan Stanley - Brokerage Accounts

    1.79%

Corporate Announcements

  • Cardinal Health, Inc. Dividends March,2024

    In the quarter ending March,2024. Cardinal Health, Inc. has declared dividend of $0.5

    Read More

Company Information

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.

Organization
Cardinal Health, Inc.
Employees
47040
CEO
Mr. Jason M. Hollar
Industry
Wholesale Trade

FAQs